Halving Women’s Alzheimer’s Risk
51:53–53:35 · 102s
Mosconi sets an audacious goal: cut women’s Alzheimer’s risk by 2050, potentially preventing 55 million cases, by pinpointing predictors and testing hormone therapy with biomarker-led trials.
51:53–53:35 · 102s
Mosconi sets an audacious goal: cut women’s Alzheimer’s risk by 2050, potentially preventing 55 million cases, by pinpointing predictors and testing hormone therapy with biomarker-led trials.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.